C5a mediates secretion and activation of matrix metalloproteinase 9 from human eosinophils and neutrophils

International Immunopharmacology

Volumn 6, Issue 7, 2006, Pages 1109-1118

  DiScipio, Richard G ^a   Schraufstatter, Ingrid U ^a   Sikora, Lyudmila ^a   Zuraw, Bruce L ^b   Sriramarao, P ^a  

^a LA JOLLA INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

C5a; Chemotaxis; Eosinophils; Gelatinase B; Neutrophils

Indexed keywords

COMPLEMENT COMPONENT C5A; GELATINASE B; NITRIC OXIDE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CHEMOTAXIS; CONFOCAL MICROSCOPY; EOSINOPHIL; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; PRIORITY JOURNAL; ZYMOGRAPHY;

ANIMALS; ANTIBODIES, MONOCLONAL; CHEMOTAXIS, LEUKOCYTE; COMPLEMENT C3A; COMPLEMENT C5A; ENZYME INHIBITORS; EOSINOPHILS; HUMANS; INTERLEUKIN-5; MATRIX METALLOPROTEINASE 9; NEUTROPHILS; NITRIC OXIDE; PYRANS; RATS;

EID: 33646596865     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.02.006     Document Type: Article

References (49)

1. Wardlaw A.J., Moqbel R., and Kay A.B. Eosinophils: biology and role in disease. Adv Immunol 60 (1995) 151-266
2. Wardlaw A.J., Walsh G.M., and Symon F.A. Mechanisms of eosinophil and basophil migration. Allergy 49 (1994) 797-807
3. Broide D., and Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev 179 (2001) 163-172
4. Yurchenco P.D., and Schittny J.C. Molecular architecture of basement membranes. FASEB J 4 (1990) 1577-1590
5. Okada S., Kita H., George T.J., Gleich G.J., and Leiferman K.M. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 17 (1997) 519-528
6. Okada S., Kita H., George T.J., Gleich G.J., and Leiferman K.M. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. Am J Respir Cell Mol Biol 16 (1997) 455-463
7. Ohno I., Ohtani H., Nitta Y., Suzuki J., Hoshi H., et al. Eosinophils as a source of matrix metalloproteinase-9 in asthmatic airway inflammation. Am J Respir Cell Mol Biol 16 (1997) 212-219
8. Birkedal-Hansen H., Moore W.G.I., Bodden M.K., Windsor L.J., Birkedal-Hanser B., et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4 (1993) 197-250
9. Mignatti P., and Rifkin D.B. Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73 (1993) 161-195
10. Chambers R.C., and Laurent G.J. Collagens. In: Crystal R.G., West J.B., Weibel E.R., and Barnes P.J. (Eds). The lung: scientific foundations (1997), Lippincott-Raven Publishers, Philadelphia 709-727
11. Fujisawa T., Kato Y., Terada A., Iguchi K., and Kamiya H. Matrix metalloproteinase-9 in peripheral blood eosinophils. Int Arch Allergy Immunol 120 Suppl. 1 (1999) 65-69
12. Van Wart H.E., and Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 87 (1990) 5578-5582
13. Hugli T.E. Biochemistry and biology of anaphylatoxins. Complement 3 (1986) 111-127
14. Botos I., Meyer E., Swanson S.M., Lemaitre V., Eeckhout Y., et al. Structure of recombinant mouse collagenase-3 (MMP-13). J Mol Biol 292 (1999) 837-844
15. DiScipio R.G., Smith C.A., Muller-Eberhard H.J., and Hugli T.E. The activation of human complement component C5 by a fluid phase C5 convertase. J Biol Chem 258 (1983) 10629-10636
16. DiScipio R.G., Daffern P.J., Jagels M.A., Broide D.H., and Sriramarao P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J Immunol 162 (1999) 1127-1136
17. Porath J., and Olin B. Immobilized metal ion affinity adsorption and immobilized metal ion affinity chromatography of biomaterials. Serum protein affinities for gel-immobilized iron and nickel ions. Biochemistry 22 (1993) 1621-1630
18. Misko T.P. A fluorometric assay for the measurement of nitrite in biological samples. Anal Biochem 214 (1993) 11-16
19. Kjeldsen L., Bjerrum O.W., Askaa J., and Borregaard N. Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules. Biochem J 287 (1992) 603-610
20. Kjeldsen L., Johnson A.H., Sengelov H., and Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 268 (1993) 10425-10432
21. O'Donnell B.V., Tew D.G., Jones O.T., and England P.J. Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase. Biochem J 290 (1993) 41-49
22. Stuehr D.J., Fasehun O.A., Lwon N.S., Gross S.S., Gonzalez J.A., et al. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5 (1991) 98-103
23. Ellis J.A., Mayer S.J., and Jones O.T. The effect of the NADPH oxidase inhibitor diphenyleneiodonium on aerobic and anaerobic microbiocidal activities of human neutrophils. Biochem J 251 (1988) 887-889
24. 6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem 37 (1994) 3886-3888
25. Bozeman P.M., Learn D.B., and Thomas E.L. Assay of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. J Immunol Methods 126 (1990) 125-133
26. Elsner J., Oppermann M.L., Czech W., Dobos G., Schopf E., et al. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol 24 (1994) 518-522
27. Gu Z., Kaul M., Yan B., Kridel S.J., Cui J., et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297 (2002) 1186-1190
28. Cedergren J., Follin P., Forslund T., Lindmark M., Sundqvist T., et al. Inducible nitric oxide synthase (NOS II) is constitutive in human neutrophils. APMIS 111 (2003) 963-968
29. MacMicking J., Xie Q.W., and Nathan C. Nitric oxide and macrophage functions. Annu Rev Immunol 15 (1997) 323-350
30. Liew F.Y. Regulation of nitric oxide synthesis in infections and autoimmune diseases. Immunol Lett 43 (1994) 95-98
31. Albina J.E. On the expression of nitric oxide synthase by human macrophages. Why no NO?. J Leukoc Biol 58 (1995) 643-649
32. Goetzl E.J., Banda M.J., and Leppert D. Matrix metalloproteinases in immunity. J Immunol 156 (1996) 1-4
33. Kumagai K., Ohno I., Okada S., Ohkawara Y., Suzuki K., et al. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol 162 (1999) 4212-4219
34. Hugli T.E. Structure and function of the anaphylatoxins. Springer Semin Immunopathol 7 (1984) 193-219
35. Fernandez H.N., Henson P.M., Otani A., and Hugli T.E. Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions. J Immunol 120 (1978) 109-115
36. Daffern P.J., Pfeifer P.H., Ember J.A., and Hugli T.E. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 181 (1995) 2119-2127
37. Hayashi H., Schellenberg R.R., Tsang S., and Roberts C.R. Matrix metalloproteinase-9 in myeloid cells: implications for allergic inflammation. Int Arch Allergy Immunol 118 (1999) 429-432
38. Pugin J., Widmer M.C., Kossodo S., Liang C.M., Preas H.L., et al. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 20 (1999) 458-464
39. Saari H., Suomalainen K., Lindy O., Konttinen Y.T., and Sorsa T. Activation of latent human neutrophil collagenase by reactive oxygen species and serine proteases. Biochem Biophy Res Commun 171 (1990) 979-987
40. Fu X., Kassim S.Y., Parks W.C., and Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of promatrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 276 (2001) 41279-41287
41. Peppin G.J., and Weiss S.J. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci U S A 83 (1986) 4322-4326
42. Weiss S.J., Peppin G., Ortiz X., Ragsdale C., and Test S.T. Oxidative autoactivation of latent collagenase by human neutrophils. Science 227 (1985) 747-749
43. Clark F.A., and Klebanoff S.J. Chronic granulomatous disease: studies of a family with impaired neutrophil chemotactic, metabolic and bactericidal function. Am J Med 65 (1978) 941-948
44. del Pozo V., de Arruda-Chaves E., de Andres B., Cardaba B., Lopez-Farre A., et al. Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. J Immunol 158 (1997) 859-864
45. Petitclerc E., and Marceau F. Relaxant effect of chemotactic peptides on rabbit vascular strips: evidence for nitric oxide release from a nonendothelial source. Blood Vessels 28 (1991) 452-463
46. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
47. Henson P.M., and Johnston R.B. Tissue injury in inflammation: oxidants, proteinases, and cationic proteins. J Clin Invest 79 (1987) 669-674
48. Schraufstatter I.U., Revak S.D., and Cochrane C.G. Proteases and oxidants in experimental pulmonary inflammatory injury. J Clin Invest 73 (1984) 1175-1184
49. Tschesche H., Knauper V., Kramer S., Michaelis J., Oberhoff R., et al. Latent collagenase and gelatinase from human neutrophils and their activation. Matrix Suppl 1 (1992) 245-255